BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Spinazzi R, Andreis PG, Rossi GP, Nussdorfer GG. Orexins in the regulation of the hypothalamic-pituitary-adrenal axis. Pharmacol Rev. 2006;58:46-57. [PMID: 16507882 DOI: 10.1124/pr.58.1.4] [Cited by in Crossref: 112] [Cited by in F6Publishing: 107] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Liguori G, Paino S, Mirabella N, Squillacioti C, De Luca A, Vittoria A. Expression of Orexin A and its Receptor 1 in the Epididymis of the South American Camelid Alpaca ( Vicugna pacos ). Anat Histol Embryol 2014;43:42-7. [DOI: 10.1111/ahe.12046] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
2 Sinton CM. Orexin/hypocretin plays a role in the response to physiological disequilibrium. Sleep Med Rev 2011;15:197-207. [PMID: 21269851 DOI: 10.1016/j.smrv.2010.12.003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
3 Ari M, Ozturk OH, Bez Y, Oktar S, Erduran D. High plasma nesfatin-1 level in patients with major depressive disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2011;35:497-500. [DOI: 10.1016/j.pnpbp.2010.12.004] [Cited by in Crossref: 57] [Cited by in F6Publishing: 52] [Article Influence: 5.2] [Reference Citation Analysis]
4 González-hernández A, Condés-lara M, García-boll E, Villalón CM. An outlook on the trigeminovascular mechanisms of action and side effects concerns of some potential neuropeptidergic antimigraine therapies. Expert Opinion on Drug Metabolism & Toxicology 2021;17:179-99. [DOI: 10.1080/17425255.2021.1856366] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
5 Cohen S, Matar MA, Vainer E, Zohar J, Kaplan Z, Cohen H. Significance of the orexinergic system in modulating stress-related responses in an animal model of post-traumatic stress disorder. Transl Psychiatry 2020;10:10. [PMID: 32066707 DOI: 10.1038/s41398-020-0698-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
6 Gołyszny M, Zieliński M, Paul-samojedny M, Filipczyk Ł, Pałasz A, Obuchowicz E. Escitalopram alters the hypothalamic OX system but does not affect its up-regulation induced by early-life stress in adult rats. Neuroscience Research 2022. [DOI: 10.1016/j.neures.2022.02.005] [Reference Citation Analysis]
7 Galvão MDOL, Sinigaglia-coimbra R, Kawakami SE, Tufik S, Suchecki D. Paradoxical sleep deprivation activates hypothalamic nuclei that regulate food intake and stress response. Psychoneuroendocrinology 2009;34:1176-83. [DOI: 10.1016/j.psyneuen.2009.03.003] [Cited by in Crossref: 55] [Cited by in F6Publishing: 55] [Article Influence: 4.2] [Reference Citation Analysis]
8 Nitkiewicz A, Smolinska N, Przala J, Kaminski T. Expression of orexin receptors 1 (OX1R) and 2 (OX2R) in the porcine ovary during the oestrous cycle. Regulatory Peptides 2010;165:186-90. [DOI: 10.1016/j.regpep.2010.07.166] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 2.6] [Reference Citation Analysis]
9 Acuna-Goycolea C, van den Pol AN. Neuroendocrine proopiomelanocortin neurons are excited by hypocretin/orexin. J Neurosci 2009;29:1503-13. [PMID: 19193897 DOI: 10.1523/JNEUROSCI.5147-08.2009] [Cited by in Crossref: 39] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
10 Smolinska N, Nitkiewicz A, Maleszka A, Kiezun M, Dobrzyn K, Czerwinska J, Chojnowska K, Kaminski T. The effect of the estrous cycle on the expression of prepro-orexin gene and protein and the levels of orexin A and B in the porcine pituitary. Animal 2014;8:300-7. [DOI: 10.1017/s1751731113002152] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 1.6] [Reference Citation Analysis]
11 Liu Y, Zhao Y, Guo L. Effects of orexin A on glucose metabolism in human hepatocellular carcinoma in vitro via PI3K/Akt/mTOR-dependent and -independent mechanism. Molecular and Cellular Endocrinology 2016;420:208-16. [DOI: 10.1016/j.mce.2015.11.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
12 Grafe LA, Eacret D, Dobkin J, Bhatnagar S. Reduced Orexin System Function Contributes to Resilience to Repeated Social Stress. eNeuro 2018;5:ENEURO. [PMID: 29662948 DOI: 10.1523/ENEURO.0273-17.2018] [Cited by in Crossref: 33] [Cited by in F6Publishing: 15] [Article Influence: 8.3] [Reference Citation Analysis]
13 Sun Y, Tisdale RK, Kilduff TS. Hypocretin/Orexin Receptor Pharmacology and Sleep Phases. Front Neurol Neurosci 2021;45:22-37. [PMID: 34052813 DOI: 10.1159/000514963] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
14 Lindqvist D, Isaksson A, Lil-träskman-bendz, Brundin L. Salivary cortisol and suicidal behavior—A follow-up study. Psychoneuroendocrinology 2008;33:1061-8. [DOI: 10.1016/j.psyneuen.2008.05.012] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 3.3] [Reference Citation Analysis]
15 Grafe LA, Geng E, Corbett B, Urban K, Bhatnagar S. Sex- and Stress-Dependent Effects on Dendritic Morphology and Spine Densities in Putative Orexin Neurons. Neuroscience 2019;418:266-78. [PMID: 31442567 DOI: 10.1016/j.neuroscience.2019.08.026] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
16 Huang M, Chen C, Chen L, Chang H, Chen C, Lin S, Xu K. Chronic ketamine abuse is associated with orexin-A reduction and ACTH elevation. Psychopharmacology 2020;237:45-53. [DOI: 10.1007/s00213-019-05342-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
17 Nitkiewicz A, Smolinska N, Maleszka A, Chojnowska K, Kaminski T. Expression of orexins and their precursor in the porcine ovary and the influence of orexins on ovarian steroidogenesis in pigs. Anim Reprod Sci 2014;148:53-62. [PMID: 24916957 DOI: 10.1016/j.anireprosci.2014.03.015] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
18 Aracri P, Banfi D, Pasini ME, Amadeo A, Becchetti A. Hypocretin (orexin) regulates glutamate input to fast-spiking interneurons in layer V of the Fr2 region of the murine prefrontal cortex. Cereb Cortex 2015;25:1330-47. [PMID: 24297328 DOI: 10.1093/cercor/bht326] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 3.2] [Reference Citation Analysis]
19 Boss C, Roch-brisbare C, Steiner MA, Treiber A, Dietrich H, Jenck F, von Raumer M, Sifferlen T, Brotschi C, Heidmann B, Williams JT, Aissaoui H, Siegrist R, Gatfield J. Structure-Activity Relationship, Biological, and Pharmacological Characterization of the Proline Sulfonamide ACT-462206: a Potent, Brain-Penetrant Dual Orexin 1/Orexin 2 Receptor Antagonist. ChemMedChem 2014;9:2486-96. [DOI: 10.1002/cmdc.201402258] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
20 Grafe LA, Bhatnagar S. The contribution of orexins to sex differences in the stress response. Brain Res 2020;1731:145893. [PMID: 30081036 DOI: 10.1016/j.brainres.2018.07.026] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
21 Navarro G, Medrano M, Aguinaga D, Vega-Quiroga I, Lillo A, Jiménez J, Casanovas M, Canela EI, Mallol J, Gysling K, Franco R. Differential effect of amphetamine over the corticotropin-releasing factor CRF2 receptor, the orexin OX1 receptor and the CRF2-OX1 heteroreceptor complex. Neuropharmacology 2019;152:102-11. [PMID: 30465812 DOI: 10.1016/j.neuropharm.2018.11.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
22 Sokołowska P, Urbańska A, Biegańska K, Wagner W, Ciszewski W, Namiecińska M, Zawilska JB. Orexins protect neuronal cell cultures against hypoxic stress: an involvement of Akt signaling. J Mol Neurosci 2014;52:48-55. [PMID: 24243084 DOI: 10.1007/s12031-013-0165-7] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 4.6] [Reference Citation Analysis]
23 Grafe LA, Eacret D, Luz S, Gotter AL, Renger JJ, Winrow CJ, Bhatnagar S. Orexin 2 receptor regulation of the hypothalamic-pituitary-adrenal (HPA) response to acute and repeated stress. Neuroscience 2017;348:313-23. [PMID: 28257896 DOI: 10.1016/j.neuroscience.2017.02.038] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 5.6] [Reference Citation Analysis]
24 Dell L, Spocter MA, Patzke N, Karlson KÆ, Alagaili AN, Bennett NC, Muhammed OB, Bertelsen MF, Siegel JM, Manger PR. Orexinergic bouton density is lower in the cerebral cortex of cetaceans compared to artiodactyls. Journal of Chemical Neuroanatomy 2015;68:61-76. [DOI: 10.1016/j.jchemneu.2015.07.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
25 Li A, Nattie E. Orexin, cardio-respiratory function, and hypertension. Front Neurosci 2014;8:22. [PMID: 24574958 DOI: 10.3389/fnins.2014.00022] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Domínguez L, Morona R, Joven A, González A, López JM. Immunohistochemical localization of orexins (hypocretins) in the brain of reptiles and its relation to monoaminergic systems. Journal of Chemical Neuroanatomy 2010;39:20-34. [DOI: 10.1016/j.jchemneu.2009.07.007] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
27 Gatfield J, Brisbare-Roch C, Jenck F, Boss C. Orexin receptor antagonists: a new concept in CNS disorders? ChemMedChem 2010;5:1197-214. [PMID: 20544785 DOI: 10.1002/cmdc.201000132] [Cited by in Crossref: 60] [Cited by in F6Publishing: 56] [Article Influence: 5.0] [Reference Citation Analysis]
28 Assisi L, Tafuri S, Liguori G, Paino S, Pavone LM, Staiano N, Vittoria A. Expression and role of receptor 1 for orexins in seminiferous tubules of rat testis. Cell Tissue Res 2012;348:601-7. [DOI: 10.1007/s00441-012-1394-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
29 Hurley SW, Johnson AK. The role of the lateral hypothalamus and orexin in ingestive behavior: a model for the translation of past experience and sensed deficits into motivated behaviors. Front Syst Neurosci 2014;8:216. [PMID: 25431553 DOI: 10.3389/fnsys.2014.00216] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
30 Merali Z, Cayer C, Kent P, Anisman H. Nesfatin-1 increases anxiety- and fear-related behaviors in the rat. Psychopharmacology 2008;201:115-23. [DOI: 10.1007/s00213-008-1252-2] [Cited by in Crossref: 103] [Cited by in F6Publishing: 99] [Article Influence: 7.4] [Reference Citation Analysis]
31 Mohammad Ahmadi Soleimani S, Azizi H, Pachenari N, Mirnajafi-zadeh J, Semnanian S. Enhancement of μ-opioid receptor desensitization by orexin-A in rat locus coeruleus neurons. Neuropeptides 2017;63:28-36. [DOI: 10.1016/j.npep.2017.03.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
32 Steiner MA, Lecourt H, Jenck F. The brain orexin system and almorexant in fear-conditioned startle reactions in the rat. Psychopharmacology (Berl) 2012;223:465-75. [PMID: 22592903 DOI: 10.1007/s00213-012-2736-7] [Cited by in Crossref: 51] [Cited by in F6Publishing: 52] [Article Influence: 5.1] [Reference Citation Analysis]
33 López M, Nogueiras R, Tena-Sempere M, Diéguez C. Orexins (hypocretins) actions on the GHRH/somatostatin-GH axis. Acta Physiol (Oxf) 2010;198:325-34. [PMID: 19769635 DOI: 10.1111/j.1748-1716.2009.02042.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
34 Han XH, Xu L, Tao SM. Effect of exogenous motilin in amygdaloid nucleus on gastric motility and its underlying mechanism in rats. Shijie Huaren Xiaohua Zazhi 2006; 14(22): 2159-2163 [DOI: 10.11569/wcjd.v14.i22.2159] [Reference Citation Analysis]
35 Rachalski A, Alexandre C, Bernard JF, Saurini F, Lesch KP, Hamon M, Adrien J, Fabre V. Altered sleep homeostasis after restraint stress in 5-HTT knock-out male mice: a role for hypocretins. J Neurosci 2009;29:15575-85. [PMID: 20007481 DOI: 10.1523/JNEUROSCI.3138-09.2009] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
36 Feng P, Vurbic D, Wu Z, Strohl KP. Brain orexins and wake regulation in rats exposed to maternal deprivation. Brain Res 2007;1154:163-72. [PMID: 17466285 DOI: 10.1016/j.brainres.2007.03.077] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 3.1] [Reference Citation Analysis]
37 Malendowicz LK, Rucinski M, Belloni AS, Ziolkowska A, Nussdorfer GG. Leptin and the regulation of the hypothalamic-pituitary-adrenal axis. Int Rev Cytol 2007;263:63-102. [PMID: 17725965 DOI: 10.1016/S0074-7696(07)63002-2] [Cited by in Crossref: 62] [Cited by in F6Publishing: 22] [Article Influence: 4.1] [Reference Citation Analysis]
38 Bai YJ, Li YH, Zheng XG, Han J, Yang XY, Sui N. Orexin A attenuates unconditioned sexual motivation in male rats. Pharmacol Biochem Behav 2009;91:581-9. [PMID: 18952120 DOI: 10.1016/j.pbb.2008.09.018] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
39 Merali Z, Cayer C, Kent P, Anisman H. Nesfatin-1 increases anxiety- and fear-related behaviors in the rat. Psychopharmacology (Berl). 2008;201:115-123. [PMID: 18670764 DOI: 10.1007/s00213- 008-1252-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
40 Dell LA, Patzke N, Bhagwandin A, Bux F, Fuxe K, Barber G, Siegel JM, Manger PR. Organization and number of orexinergic neurons in the hypothalamus of two species of Cetartiodactyla: a comparison of giraffe (Giraffa camelopardalis) and harbour porpoise (Phocoena phocoena). J Chem Neuroanat 2012;44:98-109. [PMID: 22683547 DOI: 10.1016/j.jchemneu.2012.06.001] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
41 Baddour JA, Sousounis K, Tsonis PA. Organ repair and regeneration: An overview. Birth Defects Research Part C: Embryo Today: Reviews 2012;96:1-29. [DOI: 10.1002/bdrc.21006] [Cited by in Crossref: 82] [Cited by in F6Publishing: 70] [Article Influence: 8.2] [Reference Citation Analysis]
42 Urbańska A, Sokołowska P, Woldan-Tambor A, Biegańska K, Brix B, Jöhren O, Namiecińska M, Zawilska JB. Orexins/hypocretins acting at Gi protein-coupled OX 2 receptors inhibit cyclic AMP synthesis in the primary neuronal cultures. J Mol Neurosci 2012;46:10-7. [PMID: 21547533 DOI: 10.1007/s12031-011-9526-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
43 Kushikata T, Yoshida H, Kudo M, Kudo T, Hirota K. Changes in plasma orexin A during propofol–fentanyl anaesthesia in patients undergoing eye surgery. British Journal of Anaesthesia 2010;104:723-7. [DOI: 10.1093/bja/aeq098] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
44 Barandas R, Landgraf D, Mccarthy MJ, Welsh DK. Circadian Clocks as Modulators of Metabolic Comorbidity in Psychiatric Disorders. Curr Psychiatry Rep 2015;17. [DOI: 10.1007/s11920-015-0637-2] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 6.0] [Reference Citation Analysis]
45 Tilbrook A, Clarke I. Neuroendocrine mechanisms of innate states of attenuated responsiveness of the hypothalamo-pituitary adrenal axis to stress. Frontiers in Neuroendocrinology 2006;27:285-307. [DOI: 10.1016/j.yfrne.2006.06.002] [Cited by in Crossref: 64] [Cited by in F6Publishing: 54] [Article Influence: 4.0] [Reference Citation Analysis]
46 Ziolkowska A, Rucinski M, Tyczewska M, Belloni AS, Nowak M, Nussdorfer GG, Malendowicz LK. Down-regulation of the beacon gene expression in the regenerating rat adrenal cortex. Peptides 2006;27:3216-9. [DOI: 10.1016/j.peptides.2006.09.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
47 Deutch AY, Bubser M. The orexins/hypocretins and schizophrenia. Schizophr Bull 2007;33:1277-83. [PMID: 17728265 DOI: 10.1093/schbul/sbm096] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
48 Hsueh PT, Lin HH, Wang HH, Liu CL, Ni WF, Liu JK, Chang HH, Sun DS, Chen YS, Chen YL. Immune imbalance of global gene expression, and cytokine, chemokine and selectin levels in the brains of offspring with social deficits via maternal immune activation. Genes Brain Behav 2018;17:e12479. [PMID: 29656594 DOI: 10.1111/gbb.12479] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
49 Malungo IB, Gravett N, Bhagwandin A, Davimes JG, Manger PR. A Preliminary Description of the Sleep-Related Neural Systems in the Brain of the Blue Wildebeest, Connochaetes taurinus. Anat Rec (Hoboken) 2020;303:1977-97. [PMID: 31513360 DOI: 10.1002/ar.24265] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
50 López M, Tena-Sempere M, Diéguez C. Cross-talk between orexins (hypocretins) and the neuroendocrine axes (hypothalamic-pituitary axes). Front Neuroendocrinol 2010;31:113-27. [PMID: 19654017 DOI: 10.1016/j.yfrne.2009.07.001] [Cited by in Crossref: 52] [Cited by in F6Publishing: 45] [Article Influence: 4.0] [Reference Citation Analysis]
51 Butterick TA, Billington CJ, Kotz CM, Nixon JP. Orexin: pathways to obesity resistance? Rev Endocr Metab Disord 2013;14:357-64. [PMID: 24005942 DOI: 10.1007/s11154-013-9259-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
52 Patel VH, Karteris E, Chen J, Kyrou I, Mattu HS, Dimitriadis GK, Rodrigo G, Antoniades C, Antonopoulos A, Tan BK, Hillhouse EW, Ng A, Randeva HS. Functional cardiac orexin receptors: role of orexin-B/orexin 2 receptor in myocardial protection. Clin Sci (Lond) 2018;132:2547-64. [PMID: 30467191 DOI: 10.1042/CS20180150] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
53 Kushikata T, Yoshida H, Kudo M, Kudo T, Hirota K. Plasma orexin A increases at emergence from sevoflurane-fentanyl anesthesia in patients undergoing ophthalmologic surgery. Neurosci Lett. 2010;482:212-215. [PMID: 20655366 DOI: 10.1016/j.neulet.2010.07.037] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
54 Brundin L, Björkqvist M, Petersén Å, Träskman-bendz L. Reduced orexin levels in the cerebrospinal fluid of suicidal patients with major depressive disorder. European Neuropsychopharmacology 2007;17:573-9. [DOI: 10.1016/j.euroneuro.2007.01.005] [Cited by in Crossref: 128] [Cited by in F6Publishing: 119] [Article Influence: 8.5] [Reference Citation Analysis]
55 Fitch TE, Benvenga MJ, Jesudason CD, Zink C, Vandergriff AB, Menezes MM, Schober DA, Rorick-Kehn LM. LSN2424100: a novel, potent orexin-2 receptor antagonist with selectivity over orexin-1 receptors and activity in an animal model predictive of antidepressant-like efficacy. Front Neurosci 2014;8:5. [PMID: 24478625 DOI: 10.3389/fnins.2014.00005] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
56 Ahmadi-soleimani SM, Azizi H, Gompf HS, Semnanian S. Role of orexin type-1 receptors in paragiganto-coerulear modulation of opioid withdrawal and tolerance: A site specific focus. Neuropharmacology 2017;126:25-37. [DOI: 10.1016/j.neuropharm.2017.08.024] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 7.8] [Reference Citation Analysis]
57 Heinonen MV, Purhonen AK, Mäkelä KA, Herzig KH. Functions of orexins in peripheral tissues. Acta Physiol (Oxf) 2008;192:471-85. [PMID: 18294339 DOI: 10.1111/j.1748-1716.2008.01836.x] [Cited by in Crossref: 125] [Cited by in F6Publishing: 115] [Article Influence: 8.9] [Reference Citation Analysis]
58 Li S, Wang C, Wang W, Tan J. Trait anxiety, a personality risk factor associated with Alzheimer's Disease. Prog Neuropsychopharmacol Biol Psychiatry 2021;105:110124. [PMID: 33035604 DOI: 10.1016/j.pnpbp.2020.110124] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
59 Hoch M, Hoever P, Alessi F, Theodor R, Dingemanse J. Pharmacokinetic interactions of almorexant with midazolam and simvastatin, two CYP3A4 model substrates, in healthy male subjects. Eur J Clin Pharmacol 2013;69:523-32. [PMID: 22990330 DOI: 10.1007/s00228-012-1403-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
60 Nollet M, Leman S. Role of Orexin in the Pathophysiology of Depression: Potential for Pharmacological Intervention. CNS Drugs 2013;27:411-22. [DOI: 10.1007/s40263-013-0064-z] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 5.9] [Reference Citation Analysis]
61 Merali Z, Graitson S, Mackay JC, Kent P. Stress and eating: a dual role for bombesin-like peptides. Front Neurosci 2013;7:193. [PMID: 24298233 DOI: 10.3389/fnins.2013.00193] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
62 Kaminski T, Nitkiewicz A, Smolinska N. Changes in plasma orexin A and orexin B concentrations during the estrous cycle of the pig. Peptides 2013;39:175-7. [PMID: 23220034 DOI: 10.1016/j.peptides.2012.11.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
63 Grafe LA, Bhatnagar S. Orexins and stress. Front Neuroendocrinol 2018;51:132-45. [PMID: 29932958 DOI: 10.1016/j.yfrne.2018.06.003] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 8.5] [Reference Citation Analysis]
64 Nollet M, Gaillard P, Tanti A, Girault V, Belzung C, Leman S. Neurogenesis-independent antidepressant-like effects on behavior and stress axis response of a dual orexin receptor antagonist in a rodent model of depression. Neuropsychopharmacology 2012;37:2210-21. [PMID: 22713907 DOI: 10.1038/npp.2012.70] [Cited by in Crossref: 91] [Cited by in F6Publishing: 89] [Article Influence: 9.1] [Reference Citation Analysis]
65 Lolait SJ, Stewart LQ, Jessop DS, Young WS 3rd, O'Carroll AM. The hypothalamic-pituitary-adrenal axis response to stress in mice lacking functional vasopressin V1b receptors. Endocrinology 2007;148:849-56. [PMID: 17122081 DOI: 10.1210/en.2006-1309] [Cited by in Crossref: 86] [Cited by in F6Publishing: 84] [Article Influence: 5.4] [Reference Citation Analysis]
66 Kram DE, Krasnow SM, Levasseur PR, Zhu X, Stork LC, Marks DL. Dexamethasone Chemotherapy Does Not Disrupt Orexin Signaling. PLoS One 2016;11:e0168731. [PMID: 27997622 DOI: 10.1371/journal.pone.0168731] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
67 Trachtman JN. Vision and the hypothalamus. Optometry - Journal of the American Optometric Association 2010;81:100-15. [DOI: 10.1016/j.optm.2009.07.016] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
68 Joshi D, Singh SK. Localization and expression of Orexin A and its receptor in mouse testis during different stages of postnatal development. General and Comparative Endocrinology 2017;241:50-6. [DOI: 10.1016/j.ygcen.2016.05.006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
69 Mavanji V, Georgopoulos AP, Kotz CM. Synchronous neuronal interactions in rat hypothalamic culture: a novel model for the study of network dynamics in metabolic disorders. Exp Brain Res 2021;239:755-64. [PMID: 33388905 DOI: 10.1007/s00221-020-05977-7] [Reference Citation Analysis]
70 Wang Q, Cao F, Wu Y. Orexinergic System in Neurodegenerative Diseases. Front Aging Neurosci 2021;13:713201. [PMID: 34483883 DOI: 10.3389/fnagi.2021.713201] [Reference Citation Analysis]
71 Lalonde R, Strazielle C. Neurochemical anatomy of dorsal and tonic immobility responses. Pharmacol Biochem Behav 2022;:173334. [PMID: 35026175 DOI: 10.1016/j.pbb.2022.173334] [Reference Citation Analysis]
72 Song J, Kim E, Kim CH, Song HT, Lee JE. The role of orexin in post-stroke inflammation, cognitive decline, and depression. Mol Brain 2015;8:16. [PMID: 25884812 DOI: 10.1186/s13041-015-0106-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
73 Fenzl T, Romanowski CP, Flachskamm C, Deussing JM, Kimura M. Wake-promoting effects of orexin: Its independent actions against the background of an impaired corticotropine-releasing hormone receptor system. Behav Brain Res 2011;222:43-50. [PMID: 21420442 DOI: 10.1016/j.bbr.2011.03.026] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
74 Valiante S, Liguori G, Tafuri S, Pavone LM, Campese R, Monaco R, Iachetta G, Assisi L, Mirabella N, Forte M, Costagliola A, Vittoria A. Expression and potential role of the peptide orexin-A in prostate cancer. Biochem Biophys Res Commun 2015;464:1290-6. [PMID: 26220343 DOI: 10.1016/j.bbrc.2015.07.124] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
75 Sokołowska P, Urbańska A, Namiecińska M, Biegańska K, Zawilska JB. Orexins promote survival of rat cortical neurons. Neurosci Lett 2012;506:303-6. [PMID: 22138089 DOI: 10.1016/j.neulet.2011.11.028] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
76 Schmidt FM, Arendt E, Steinmetzer A, Bruegel M, Kratzsch J, Strauß M, Baum P, Hegerl U, Schönknecht P. CSF-hypocretin-1 levels in patients with major depressive disorder compared to healthy controls. Psychiatry Research 2011;190:240-3. [DOI: 10.1016/j.psychres.2011.06.004] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
77 Dejager L, Pinheiro I, Puimège L, Fan YD, Gremeaux L, Vankelecom H, Libert C. Increased glucocorticoid receptor expression and activity mediate the LPS resistance of SPRET/EI mice. J Biol Chem 2010;285:31073-86. [PMID: 20663891 DOI: 10.1074/jbc.M110.154484] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
78 Bahramzadeh Zoeram S, Elahdadi Salmani M, Lashkarbolouki T, Goudarzi I. Hippocampal orexin receptor blocking prevented the stress induced social learning and memory deficits. Neurobiol Learn Mem 2019;157:12-23. [PMID: 30458283 DOI: 10.1016/j.nlm.2018.11.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
79 Ozsoy S, Olguner Eker O, Abdulrezzak U, Esel E. Relationship between orexin A and childhood maltreatment in female patients with depression and anxiety. Social Neuroscience 2016;12:330-6. [DOI: 10.1080/17470919.2016.1169216] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
80 Valiante S, Liguori G, Tafuri S, Campese R, Monaco R, Paino S, Laforgia V, Staiano N, Vittoria A. Expression of orexin A and its receptor 1 in the human prostate. J Anat 2013;222:473-80. [PMID: 23425077 DOI: 10.1111/joa.12030] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
81 Hoch M, Hoever P, Alessi F, Marjason J, Dingemanse J. Pharmacokinetics and Tolerability of Almorexant in Japanese and Caucasian Healthy Male Subjects. Pharmacology 2011;88:121-6. [DOI: 10.1159/000330098] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
82 Nollet M, Gaillard P, Minier F, Tanti A, Belzung C, Leman S. Activation of orexin neurons in dorsomedial/perifornical hypothalamus and antidepressant reversal in a rodent model of depression. Neuropharmacology 2011;61:336-46. [PMID: 21530551 DOI: 10.1016/j.neuropharm.2011.04.022] [Cited by in Crossref: 70] [Cited by in F6Publishing: 69] [Article Influence: 6.4] [Reference Citation Analysis]
83 Bez Y, Ari M, Ozturk OH, Oktar S, Can Y. Increased Plasma Nesfatin-1 Levels in Patients with Obsessive Compulsive Disorder. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology 2016;22:5-9. [DOI: 10.5455/bcp.20110627110925] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
84 Pałasz A, Lapray D, Peyron C, Rojczyk-Gołębiewska E, Skowronek R, Markowski G, Czajkowska B, Krzystanek M, Wiaderkiewicz R. Dual orexin receptor antagonists - promising agents in the treatment of sleep disorders. Int J Neuropsychopharmacol 2014;17:157-68. [PMID: 23702225 DOI: 10.1017/S1461145713000552] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
85 Kaminski T, Smolinska N, Nitkiewicz A, Przala J. Expression of orexin receptors 1 (OX1R) and 2 (OX2R) in the porcine pituitary during the oestrous cycle. Animal Reproduction Science 2010;117:111-8. [DOI: 10.1016/j.anireprosci.2009.03.007] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
86 Bez Y, Ari M, Ozturk OH, Oktar S, Can Y, Sogut S. Plasma Nesfatin-1 Level May Be Associated with Disease Severity in Patients with Panic Disorder. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology 2016;20:288-92. [DOI: 10.1080/10177833.2010.11790674] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
87 Kukkonen JP. Physiology of the orexinergic/hypocretinergic system: a revisit in 2012. Am J Physiol Cell Physiol 2013;304:C2-32. [PMID: 23034387 DOI: 10.1152/ajpcell.00227.2012] [Cited by in Crossref: 93] [Cited by in F6Publishing: 91] [Article Influence: 9.3] [Reference Citation Analysis]
88 Borsook D, Erpelding N, Lebel A, Linnman C, Veggeberg R, Grant PE, Buettner C, Becerra L, Burstein R. Sex and the migraine brain. Neurobiol Dis 2014;68:200-14. [PMID: 24662368 DOI: 10.1016/j.nbd.2014.03.008] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 5.4] [Reference Citation Analysis]
89 Ragionieri L, Ravanetti F, Di Lecce R, Botti M, Ciccimarra R, Bussolati S, Basini G, Gazza F, Cacchioli A. Immunolocalization of Orexin A and its receptors in the different structures of the porcine ovary. Ann Anat 2018;218:214-26. [PMID: 29738835 DOI: 10.1016/j.aanat.2018.04.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
90 Biegańska K, Sokołowska P, Jöhren O, Zawilska JB. Orexin A suppresses the growth of rat C6 glioma cells via a caspase-dependent mechanism. J Mol Neurosci 2012;48:706-12. [PMID: 22588980 DOI: 10.1007/s12031-012-9799-0] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
91 Gallo-Payet N, Battista MC. Steroidogenesis-adrenal cell signal transduction. Compr Physiol 2014;4:889-964. [PMID: 24944026 DOI: 10.1002/cphy.c130050] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 5.6] [Reference Citation Analysis]
92 Tsuneki H, Wada T, Sasaoka T. Role of orexin in the regulation of glucose homeostasis. Acta Physiologica 2010;198:335-48. [DOI: 10.1111/j.1748-1716.2009.02008.x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 36] [Article Influence: 3.8] [Reference Citation Analysis]
93 Postigo A. Difluoromethylation of Bioactive Compounds. Late-Stage Fluorination of Bioactive Molecules and Biologically-Relevant Substrates. Elsevier; 2019. pp. 243-85. [DOI: 10.1016/b978-0-12-812958-6.00008-2] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
94 Maurovich-horvat E, Keckeis M, Lattová Z, Kemlink D, Wetter T, Schuld A, Sonka K, Pollmächer T. Hypothalamo-pituitary-adrenal axis, glucose metabolism and TNF- α in narcolepsy. J Sleep Res 2014;23:425-31. [DOI: 10.1111/jsr.12138] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
95 López JM, Domínguez L, Moreno N, González A. Comparative immunohistochemical analysis of the distribution of orexins (hypocretins) in the brain of amphibians. Peptides 2009;30:873-87. [DOI: 10.1016/j.peptides.2009.01.013] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
96 Lindqvist D, Janelidze S, Erhardt S, Träskman-bendz L, Engström G, Brundin L. CSF biomarkers in suicide attempters - a principal component analysis: CSF biomarkers in suicide attempters. Acta Psychiatrica Scandinavica 2011;124:52-61. [DOI: 10.1111/j.1600-0447.2010.01655.x] [Cited by in Crossref: 50] [Cited by in F6Publishing: 39] [Article Influence: 4.2] [Reference Citation Analysis]
97 Williams JT, Gatfield J, Roch C, Treiber A, Jenck F, Bolli MH, Brotschi C, Sifferlen T, Heidmann B, Boss C. Discovery and optimisation of 1-acyl-2-benzylpyrrolidines as potent dual orexin receptor antagonists. Med Chem Commun 2015;6:1054-64. [DOI: 10.1039/c5md00074b] [Cited by in Crossref: 5] [Article Influence: 0.7] [Reference Citation Analysis]
98 Khairuddin S, Aquili L, Heng BC, Hoo TLC, Wong KH, Lim LW. Dysregulation of the orexinergic system: A potential neuropeptide target in depression. Neuroscience & Biobehavioral Reviews 2020;118:384-96. [DOI: 10.1016/j.neubiorev.2020.07.040] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
99 Kim SJ, Pilowsky PM, Farnham MM. Intrathecal Intermittent Orexin-A Causes Sympathetic Long-Term Facilitation and Sensitizes the Peripheral Chemoreceptor Response to Hypoxia in Rats. J Pharmacol Exp Ther 2016;358:492-501. [PMID: 27384072 DOI: 10.1124/jpet.116.234443] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
100 Brundin L, Petersén Å, Björkqvist M, Träskman-bendz L. Orexin and psychiatric symptoms in suicide attempters. Journal of Affective Disorders 2007;100:259-63. [DOI: 10.1016/j.jad.2006.10.019] [Cited by in Crossref: 51] [Cited by in F6Publishing: 46] [Article Influence: 3.4] [Reference Citation Analysis]
101 Morina IY, Aristakesyan EA, Kuzik VV, Oganesyan GA, Alekseeva OS. On the influence of prenatal hypoxia on formation of the orexinergic system and sleep–wake cycle in early ontogenesis of rats. J Evol Biochem Phys 2016;52:238-45. [DOI: 10.1134/s0022093016030066] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
102 Emul M, Karamustafalioglu N, Kalelioglu T, Genc A, Tasdemir A, Gungor FC, Incir S, Seven A. The nesfatin 1 level in male patients with manic episode and alterations of nesfatin 1 level after antipsychotic and electroconvulsive treatment. Journal of Affective Disorders 2013;151:849-53. [DOI: 10.1016/j.jad.2013.08.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
103 Li A, Nattie E. Orexin, cardio-respiratory function, and hypertension. Front Neurosci 2014;8:22. [PMID: 24574958 DOI: 10.3389/fnins.2014.00022] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]
104 Tsuneki H, Murata S, Anzawa Y, Soeda Y, Tokai E, Wada T, Kimura I, Yanagisawa M, Sakurai T, Sasaoka T. Age-related insulin resistance in hypothalamus and peripheral tissues of orexin knockout mice. Diabetologia 2008;51:657-67. [PMID: 18256806 DOI: 10.1007/s00125-008-0929-8] [Cited by in Crossref: 88] [Cited by in F6Publishing: 74] [Article Influence: 6.3] [Reference Citation Analysis]
105 Chen Q, de Lecea L, Hu Z, Gao D. The hypocretin/orexin system: an increasingly important role in neuropsychiatry. Med Res Rev 2015;35:152-97. [PMID: 25044006 DOI: 10.1002/med.21326] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 5.5] [Reference Citation Analysis]
106 Grafe LA, Cornfeld A, Luz S, Valentino R, Bhatnagar S. Orexins Mediate Sex Differences in the Stress Response and in Cognitive Flexibility. Biol Psychiatry 2017;81:683-92. [PMID: 27955897 DOI: 10.1016/j.biopsych.2016.10.013] [Cited by in Crossref: 49] [Cited by in F6Publishing: 42] [Article Influence: 8.2] [Reference Citation Analysis]
107 Fenzl T, Flachskamm C, Rossbauer M, Deussing JM, Kimura M. Circadian rhythms of basal orexin levels in the hypothalamus are not influenced by an impaired corticotropin-releasing hormone receptor type 1 system. Behav Brain Res 2009;203:143-5. [PMID: 19379774 DOI: 10.1016/j.bbr.2009.04.012] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
108 Suzuki H, Miyoshi Y, Yamamoto T. Orexin-A (hypocretin 1)-like immunoreactivity in growth hormone-containing cells of the Japanese seaperch (Lateolabrax japonicus) pituitary. General and Comparative Endocrinology 2007;150:205-11. [DOI: 10.1016/j.ygcen.2006.08.008] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
109 Jin K, Lu J, Yu Z, Shen Z, Li H, Mou T, Xu Y, Huang M. Linking peripheral IL-6, IL-1β and hypocretin-1 with cognitive impairment from major depression. J Affect Disord 2020;277:204-11. [PMID: 32829196 DOI: 10.1016/j.jad.2020.08.024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
110 Tang Z, Xu J, Yin L, Yin D, Zhu M, Yu M, Li X, Zhao S, Liu X. Genome-Wide Association Study Reveals Candidate Genes for Growth Relevant Traits in Pigs. Front Genet 2019;10:302. [PMID: 31024621 DOI: 10.3389/fgene.2019.00302] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
111 Czerwinska J, Chojnowska K, Kaminski T, Bogacka I, Smolinska N, Kaminska B. Prepro-orexin and orexin expression in the hypothalamic–pituitary–adrenal and hypothalamic–pituitary–gonadal axes of free-living Eurasian beavers (Castor fiber L.) depends on season. Journal of Mammalogy 2017;98:895-905. [DOI: 10.1093/jmammal/gyx041] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]